Search results for "Vaccination"
New guidelines on COVID-19 antibody testing, flu vaccination and trial data on remdesivir
Infectious diseases experts offered guidance on the use of antibody tests in practice, a remdesivir trial showed disappointing results, the CDC recommended flu vaccination for people six months and up, and a study reported post-ICU outcomes of patients with COVID-19.
https://immattersacp.org/weekly/archives/2020/08/25/1.htm
25 Aug 2020
ACP releases guidebook on aging, immunity, and importance of vaccination
A free guidebook reinforces the importance of immunization among older adults, especially for vaccine-preventable diseases such as shingles, pneumonia, and influenza.
https://immattersacp.org/weekly/archives/2017/12/19/4.htm
19 Dec 2017
Distribution plans, data on vaccines; NIH cautious on latest antibody treatment
The Advisory Committee on Immunization Practices chose clinicians and long-term care residents for priority vaccination, while ACP offered additional input on the topic. The NIH said that casirivimab plus imdevimab should not be standard of care, and the CDC offered recommendations on shortening quarantine.
https://immattersacp.org/weekly/archives/2020/12/08/1.htm
8 Dec 2020
Studies find monoclonal antibodies and remdesivir effective, while vaccine-associated myocarditis is rare
A trial of casirivimab plus imdevimab indicated it reduced risk of hospitalization or death, the CDC urged vaccination during pregnancy and updated its v-safe tool, and an analysis showed that postvaccine myocarditis occurred in men and resolved with conservative treatment.
https://immattersacp.org/weekly/archives/2021/10/05/1.htm
5 Oct 2021
COVID-19 outcomes in health care workers and over the long term, vaccine evidence and uptake among the latest research
A study found that health care workers hospitalized with COVID-19 had shorter stays, while a survey showed high uncertainty about vaccination. Johnson & Johnson released efficacy data on a one-shot vaccine, and a study identified long-term decreases in function among COVID-19 survivors.
https://immattersacp.org/weekly/archives/2021/02/02/1.htm
2 Feb 2021
Answers and even more questions on COVID-19 vaccines
In a fourth forum from ACP and Annals of Internal Medicine, infectious disease experts Carlos del Rio, MD, FACP, Paul Sax, MD, and Deborah Cotton, MD, MPH, FACP, discussed COVID-19 vaccines and their implementation, as well as other aspects of the pandemic response.
https://immattersacp.org/weekly/archives/2021/03/30/2.htm
30 Mar 2021
One-fifth of COVID-19 patients taking nirmatrelvir-ritonavir had viral rebound
A small observational study of ambulatory patients with COVID-19 found that 1.8% of untreated patients tested positive again after testing negative, compared to 20.8% of those who took five days of nirmatrelvir-ritonavir.
https://immattersacp.org/weekly/archives/2023/11/14/4.htm
14 Nov 2023
Latest on COVID-19 and bamlanivimab, vaccines, long-term effects
Bamlanivimab reduced viral load in mild to moderate cases when combined with etesevimab, new vaccine recommendations, research, and educational resources were released, and two studies provided longer-term data on patients who had COVID-19.
https://immattersacp.org/weekly/archives/2021/01/26/1.htm
26 Jan 2021
Q&A with ACP's President on COVID-19 vaccines
George M. Abraham, MD, MPH, MACP, ACP's President, recently discussed the difference between third shots and boosters and other complexities of vaccination, as well as offered advice to internists on getting more patients vaccinated.
https://immattersacp.org/weekly/archives/2021/11/23/1.htm
23 Nov 2021
COVID-19 research focused on anticoagulation, vaccine-induced thrombocytopenia
Two new studies support prophylactic, rather than therapeutic, anticoagulation for COVID-19 patients, and case reports provide more information about vaccine-induced immune thrombotic thrombocytopenia.
https://immattersacp.org/weekly/archives/2021/06/15/1.htm
15 Jun 2021